JPH0259513A - Oral cavity mucosa-attaching type halitosis-preventing agent - Google Patents

Oral cavity mucosa-attaching type halitosis-preventing agent

Info

Publication number
JPH0259513A
JPH0259513A JP63209797A JP20979788A JPH0259513A JP H0259513 A JPH0259513 A JP H0259513A JP 63209797 A JP63209797 A JP 63209797A JP 20979788 A JP20979788 A JP 20979788A JP H0259513 A JPH0259513 A JP H0259513A
Authority
JP
Japan
Prior art keywords
halitosis
film
water
oral mucosa
soluble film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63209797A
Other languages
Japanese (ja)
Other versions
JPH0541602B2 (en
Inventor
Yuichi Hisae
久重 祐一
Hitoshi Takayanagi
均 高柳
Yoshihiro Sawai
沢井 義弘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KIYUUKIYUU YAKUHIN KOGYO KK
Kyukyu Pharmaceutical Co Ltd
Original Assignee
KIYUUKIYUU YAKUHIN KOGYO KK
Kyukyu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KIYUUKIYUU YAKUHIN KOGYO KK, Kyukyu Pharmaceutical Co Ltd filed Critical KIYUUKIYUU YAKUHIN KOGYO KK
Priority to JP63209797A priority Critical patent/JPH0259513A/en
Publication of JPH0259513A publication Critical patent/JPH0259513A/en
Publication of JPH0541602B2 publication Critical patent/JPH0541602B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To provide the subject agent having remarkable odor-modifying, taste- modifying and deodorizing actions, preventing halitosis and having fast-acting and persisting properties without a feeling of physical disorder by comprising a water-soluble film which contains an active ingredient having a halitosis- preventing effect and is attached to an oral mucosa. CONSTITUTION:The subject agent comprises a water-soluble film which contains an active ingredient having a halitosis-preventing effect and is attached to an oral mucosa. The active ingredient is selected from l-menthol, dl-camphor, peppermint oil, fennel fruit oil, gambir-catechu, etc., which exhibit mainly taste- modifying and odor-modifying, the content of the active ingredient being 0.1-5wt.%. A compound exhibiting the deodorizing effect includes flavonoid, cetylpyridinium chloride, etc., and the content of the compound is preferably 0.01-5wt.%. These active ingredients are preferably mixed and dispersed in a water-soluble film such as gelatin film and the thickness of the film is preferably 15-330mum.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は口腔内に直接貼付することにより口臭を消すこ
とができる口腔粘膜貼付型口臭防止剤に関するものであ
る。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Field of Application) The present invention relates to an oral mucosal adhesive type anti-halitosis agent that can eliminate bad breath by directly applying it to the oral cavity.

(従来の技術) 従来使用されている口臭防止剤の剤型として液剤、練薬
、噴霧剤、トローチ剤、火剤がある。液剤、練薬は口腔
内洗浄後の処理に難点があり、いつ、どこでも使えると
いう訳ではない。噴霧剤、トローチ剤、火剤においては
、携帯し易く、使い易いが、噴霧剤は持続性がない。さ
らにトローチ剤、火剤においては、違和感がある為、会
話等に支障を生じ、かみくだかれ、飲み込まれたりし易
く、効き目がザぐなくなる欠点がある。以上のことより
従来品では持続性はのぞめない。
(Prior Art) Conventionally used formulations of anti-halitosis agents include liquids, powders, sprays, lozenges, and gunpowders. Liquid preparations and powder preparations have the disadvantage of being difficult to dispose of after oral irrigation, and cannot be used anytime and anywhere. Sprays, lozenges, and gun powder are easy to carry and use, but sprays are not persistent. In addition, lozenges and gunpowder have the disadvantage that they have an unpleasant sensation, hinder conversation, etc., are easily chewed or swallowed, and are less effective. For the above reasons, conventional products cannot be expected to be sustainable.

(技術的課題) そこで本発明者らは鋭意研究を川ね、どのような剤形が
この種の用途には最適であるかを検討したところ、口腔
内の粘膜に付着し、容易に剥落しないこと、敏感な箇所
であるため可能な限り違和感をおぼえない形態、性状で
あること、持続性及び徐放性があることなどが必要で、
この条件をみたすものはフィルム状の貼付剤である。
(Technical Issue) Therefore, the present inventors conducted extensive research to determine what kind of dosage form would be optimal for this type of use. In addition, since it is a sensitive area, it is necessary that the shape and properties cause as little discomfort as possible, and that it is long-lasting and has sustained release properties.
A film-like adhesive patch satisfies this condition.

またフィルム状貼付剤に含有させる口臭防止の有効成分
としては矯味、矯臭及び消臭効果を発揮するものである
必要がある。
In addition, the active ingredient for preventing bad breath contained in the film-like patch must exhibit taste-correcting, odor-correcting, and deodorizing effects.

したがって、本発明の目的は口臭防止の有効成。Therefore, the object of the present invention is to provide an effective composition for preventing bad breath.

分を含有するフィルム状の貼付剤であって、かつそのフ
ィルムは少なくとも水溶性フィルムであり、溶けながら
有効成分を放出させる徐放性の口腔粘膜貼付型口臭防止
剤を提供することにある。
An object of the present invention is to provide a sustained-release oral mucosal patch-type halitosis preventive agent, which is a film-like adhesive patch containing at least a water-soluble film, and which releases an active ingredient while dissolving.

(技術的手段) 前記目的は、口臭防止効果を有する有効成分を含有し、
口腔粘膜に付着する水溶性フィルムより成る口腔粘膜貼
付型口臭防止剤によって達成される。
(Technical means) The purpose is to contain an active ingredient having an anti-halitosis effect,
This is achieved by an oral mucosal adhesive type anti-halitosis agent made of a water-soluble film that adheres to the oral mucosa.

有効成分としては(−メントール、d−カンフル、ハツ
カ油、ウィキョウ油、アセンヤク、カン。
Active ingredients include (-menthol, d-camphor, peppermint oil, fennel oil, acaenia oil, and camphor.

ゾウ、クロロフィリン誘導体、ケイヒ、コシヨウ、シュ
クシャ、ショウキョウ、チョウジ、トウガラシ、U−メ
ン1−−ル、ヒャクソウ、モッコウ、ヤクチ、リュウノ
ウ、ニクズク、ヂョウジ油、ケイヒ油、サフラン、ロー
ズ油、抹茶から選ばれた1種又は2種以上を含有さUる
ことができる。これらは主として矯味、矯臭効果を発揮
し、各有効成分の含有比率はff1ffi比で0.1〜
5%とする。
Selected from elephant, chlorophyllin derivatives, cinnamon bark, koshiyo, shukusha, ginger, clove, chili pepper, U-men 1-le, hyakuso, mokko, yakuchi, rhyuno, nikuzuku, ginger oil, cinnamon bark oil, saffron, rose oil, matcha It is possible to contain one or more of the following. These mainly exert flavor correction and odor correction effects, and the content ratio of each active ingredient is from 0.1 to ff1ffi ratio.
5%.

また他の有効成分としてはフラボノイド、塩化セチルピ
リジニウム、1JlliQクロルヘキシジン、塩化デカ
リニウム、グルコン酸クロルヘキシジンから選ばれた1
種又は2種以上を含イフさせることができる。これらは
主として消臭効果を発揮するもので、各有効成分の含有
比率は重量比で0.01〜5%が良い。夫々0.1%或
いは0.01%以下では稀薄に過ぎ所期の口臭防止効果
が得られないし、5%を越えても効果の向上は期待でき
ないからである。なお矯味、矯臭効果を主とする有効成
分と、消臭効果を主とする有効成分とは薬理上問題がな
Other active ingredients include 1 selected from flavonoids, cetylpyridinium chloride, 1JlliQ chlorhexidine, dequalinium chloride, and chlorhexidine gluconate.
A species or two or more species can be included. These mainly exhibit a deodorizing effect, and the content ratio of each active ingredient is preferably 0.01 to 5% by weight. This is because if it is less than 0.1% or 0.01%, respectively, it is too dilute and the desired halitosis prevention effect cannot be obtained, and if it exceeds 5%, no improvement in the effect can be expected. Note that there is no pharmacological problem between active ingredients that primarily have flavor-correcting and odor-correcting effects and active ingredients that primarily have deodorizing effects.

い限り併用することができる(請求項第4項)。They can be used together as long as possible (Claim 4).

以上のような口臭防止の有効成分は水溶性フィルム中に
均一に混合、分散させることが必須不可欠であり、同フ
ィルムに塗布菖しくは埋設させただけでは本発明の目的
は達成できない。
It is essential that the above-mentioned effective ingredients for preventing bad breath are uniformly mixed and dispersed in a water-soluble film, and the object of the present invention cannot be achieved simply by coating or embedding them in the film.

前記水溶性フィルムは主に口腔内から胃内ひ溶けるもの
を相称する。水溶性フィルムとしては、ポリビニルピロ
リドン、ゼラチン、ポリごニルアルコール、ポリアクリ
ル酸ナトリウム、カルボ4−ジメチルセルロース、デン
プン、キ著ナンタンガムカラヤガム、アルギン酸ナトリ
ウム、メチルセルロース、カルボキシビニルポリマー、
カンテン及び、ヒドロキシプロピルセル(コースがあげ
られ、これらの1種又は2種以上を主体に構成する。
The water-soluble film mainly refers to a film that dissolves in the oral cavity and stomach. Water-soluble films include polyvinylpyrrolidone, gelatin, polygonyl alcohol, sodium polyacrylate, carbo-4-dimethylcellulose, starch, nanthanum gum karaya gum, sodium alginate, methylcellulose, carboxyvinyl polymer,
Examples include agar and hydroxypropyl cell (coase), and it is mainly composed of one or more of these.

このように水溶性フィルムは可食性でありかつ水溶性で
あることが必要であるが、それだけでは十分でなく製剤
として厚くならない構造でなりれぼならない。具体的に
は水溶性フィルムの溶解速度と薬効の持続及び違和感等
どのかね合いからその厚さが決定される。薄過ぎるとフ
ィルム剤にもよるが早く溶けずざるので15μm以上が
良い。−方最大厚さは個人差があるけれども、製剤状態
で400μm以下、より好ましくは330μm以下が良
く、それ以上になると多数の者が違和感を覚えるように
なる。
As described above, it is necessary for the water-soluble film to be both edible and water-soluble, but this alone is not sufficient and the formulation must have a structure that does not become thick. Specifically, the thickness of the water-soluble film is determined based on the balance between the dissolution rate of the water-soluble film, the duration of its medicinal efficacy, and the sense of discomfort. If it is too thin, it will not dissolve quickly, although it depends on the film material, so the thickness is preferably 15 μm or more. Although the maximum thickness varies from person to person, it is preferably 400 .mu.m or less, more preferably 330 .mu.m or less in the form of a preparation; if it is more than that, many people will feel uncomfortable.

有効成分を薄いフィルム中に均一に含有させかつ剤厚を
制御するには、前記成分及び薄層フィルムを形成可能な
物質を溶解、或いは混合分散せしめる溶媒の選定も重要
である。
In order to uniformly contain the active ingredient in a thin film and control the thickness of the film, it is also important to select a solvent that can dissolve or mix and disperse the ingredients and the substance capable of forming a thin film.

この種の溶媒は、当該製剤が口腔内に使用され体内に入
ることから、人体に対して有害な作用を有するものであ
ってはならないのは当然である。
Naturally, this type of solvent must not have any harmful effects on the human body since the preparation is used in the oral cavity and enters the body.

また、展延後溶媒を留去することから、ある程度比熱の
小さいもの、さらに、溶媒間についても溶媒留去の点で
出来るだけ少ない吊で、必要な薬物量を溶解せしめる溶
媒でなければならない。
Furthermore, since the solvent is distilled off after spreading, it is necessary to use a solvent that has a relatively low specific heat and that can dissolve the required amount of drug with as little friction as possible in terms of solvent distillation.

以上の点を考慮した結果、本発明では溶剤を水、エタノ
ール、塩化メチレンに限定し、その上で貼付剤を形成す
るために必要・な諸成分を選定することとしたもので、
それによって剤厚を15〜330μmに制御することが
可能になった。
As a result of considering the above points, the present invention limits the solvent to water, ethanol, and methylene chloride, and then selects the various components necessary to form the patch.
This made it possible to control the agent thickness to 15 to 330 μm.

なお、水溶性フィルムは溶解速度の差により連発性(即
発性)のもの°と遅発性のものに大別し、これらを夫々
単独で、或いは適宜組合せて口臭防止剤の基材を構成す
ることができる。
In addition, water-soluble films are roughly divided into rapid-onset (immediate-onset) and delayed-onset films depending on the dissolution rate, and these films may be used alone or in appropriate combinations to constitute the base material of the halitosis preventive agent. be able to.

(作用) 以上の如く構成された本発明の口臭防止剤において、有
効成分は水溶性フィルム中に含有されているので、この
フィルムが口腔内で溶【プるにしたがって、有効成分も
それが貼付された部分より口腔内全域に拡散し作用する
(Function) In the anti-halitosis agent of the present invention configured as described above, the active ingredient is contained in the water-soluble film, so as this film dissolves in the oral cavity, the active ingredient also dissolves in the water-soluble film. It spreads and acts throughout the oral cavity from the affected area.

特に本発明における水溶性フィルムはその全体が貼付部
分の形状に適応して口腔内粘膜に付着するので、フィル
ムに薬物を埋設したり塗布したものに対して、口腔内全
域へ効果の及ぶのが早い。
In particular, the water-soluble film of the present invention adapts to the shape of the part to be applied and adheres to the oral mucosa, so it is more effective to reach the entire oral cavity than when a drug is embedded or applied to the film. early.

そうした構造的主成分と的確な薬効が相乗し口腔内の臭
味に対して速やかな矯臭作用によるマスキング、或いは
消臭作用により、口臭を消すことができる。またfal
Fiフィルムによって水溶性フィルムを構成し、−層を
遅発溶解性フィルムとしたときは、溶解時間が著しく延
長される結果、長時間に亘り口臭防止作用が持続する。
The synergistic effect of these structural main components and precise medicinal effects makes it possible to eliminate bad breath by quickly masking the odor and taste in the oral cavity with its odor-correcting action, or by its deodorizing action. Also fal
When the water-soluble film is constituted by the Fi film and the negative layer is a slow-dissolving film, the dissolution time is significantly extended, and as a result, the halitosis prevention effect continues for a long time.

(効果) 本発明の口臭除去効果及び持続性を客観的に明らかにす
るために、ガスクロマトグラフィーによる分析をこころ
みた。口臭に含まれると考えられる揮発性悪臭物質とし
て、メチルメルカプタンを選び、1度マウスウォッシュ
で口腔内を洗浄後、人口口臭10aeで1分間うがいし
、吐きだした直後に各口臭防止剤を投与する。そして経
時的に呼気のベツドスペースガスをガスクロマトグラフ
ィーによって分析した。その結果を次表及び第6図に示
す。
(Effect) In order to objectively clarify the halitosis removing effect and sustainability of the present invention, analysis by gas chromatography was attempted. Methyl mercaptan is selected as a volatile malodorous substance thought to be included in bad breath, and after washing the inside of the oral cavity once with mouthwash, gargling with artificial halitosis 10ae for 1 minute, and immediately after spitting it out, administer each anti-halitosis agent. Bedspace gases in exhaled breath were analyzed over time by gas chromatography. The results are shown in the following table and Figure 6.

経時的メチルメルカプタンの残存率(%)以上の結果よ
り本発明(実施例33)以外のものはいずれも20分間
前後で効果がなくなり、再び人口口臭が復活することを
確認出来た。しかし本発明によるものは、20分で60
%のメチルメルカプタンを消臭しかつその状態で2時間
持続した。
From the results of the residual rate (%) of methyl mercaptan over time, it was confirmed that all the products other than the present invention (Example 33) lost their effectiveness after about 20 minutes, and the artificial halitosis returned again. However, according to the present invention, 60% in 20 minutes
% of methyl mercaptan and remained so for 2 hours.

以上のように本発明のものは有効成分を水溶性フィルム
に含有させた構成を有し、顕著な矯臭、矯味及び消臭作
用により口臭を防止することができ、しかも薄いフィル
ム状で口腔粘着に付着しているため違和感も起らず、即
効性と持続性により実用上優れた効果を発揮した。
As described above, the product of the present invention has a structure in which the active ingredient is contained in a water-soluble film, and can prevent bad breath due to its remarkable odor correction, flavor correction and deodorization effects.Moreover, it is in the form of a thin film and has no oral adhesive properties. Because it was adhered to the skin, it did not cause any discomfort, and it exhibited excellent practical effects due to its immediate and long-lasting effect.

(実施例) 次に本発明の実施例を示すが、本発明はこれに特定され
るものではない。
(Example) Next, an example of the present invention will be shown, but the present invention is not limited to this.

図面は、水溶性フィルムが単層の連発溶解性フィルム1
のみからなるもの(第1図)、遅発溶解性の単層フィル
ム2のみからなるもの(第2図)、。
The drawing shows continuous dissolvable film 1 with a single layer of water-soluble film.
(FIG. 1), and one (FIG. 2) consisting only of a slow-dissolving single-layer film 2.

前記両フィルム1.2の複層フィルムからなるもの(第
3図)及び中心の遅発溶解性フィルム2の外層に連発溶
解層1.1を貼合した3層の積層フィルムとした例(第
4図)“を示す。いずれのフィルム1.2も、口腔自活
!I!J3に密着するとそこに接着するが、他の面は常
時唾液が作用するため接着性を喪失した状態になる(第
5図)。連発溶解性フィルムは即効効果を、遅発溶解フ
ィルムは持続効果を夫々前るために設けられるが、いず
れのフィルムもポリビニルピロリドン、ゼラチン、ポリ
ビニルアルコール、ポリアクリル酸ナトリウム、カルボ
キシメチルセルロース、デンプン、キサンタンガム、カ
ラヤガム、アルギン酸ナトリウム、メチルセルロース、
カルボキシビニルポリマーカンテン、ヒドロキシプロピ
ルセルロース等から選ばれた1種又は2種以上からなる
口腔内可溶性フィルムよによって構成され、各成分の比
率等によって溶解時間の遅速が調整される。
An example of a multilayer film consisting of both films 1.2 (Fig. 3) and a three-layer laminated film in which the continuous dissolution layer 1.1 is laminated to the outer layer of the slow dissolution film 2 in the center (Fig. 3). When both films 1 and 2 come into close contact with Oral Self-Sufficiency! (Figure 5).The rapid dissolving film is designed to provide an immediate effect, and the delayed dissolving film is provided to provide a sustained effect, but both films contain polyvinylpyrrolidone, gelatin, polyvinyl alcohol, sodium polyacrylate, carboxymethyl cellulose, Starch, xanthan gum, karaya gum, sodium alginate, methylcellulose,
It is composed of an intraorally soluble film made of one or more selected from carboxyvinyl polymer agar, hydroxypropyl cellulose, etc., and the dissolution time is adjusted depending on the ratio of each component.

なお各有効成分はフィルム全体に含有されている。Note that each active ingredient is contained throughout the film.

〈実施例1) 連発溶解性フィルム(接着層):有効成分として第1表
実施例1に示す℃−メントール2.5重量部、ハツカ油
2.0重量部、ウィキョウ1.0重量部を、ヒドロキシ
ブロビルセルース(1−I P C−H)10重置部、
ヒドロキシプロピルセルロース(HPC−L)30重量
部、ポリビニルピロリドン(PVP ) 44.5ff
lffi部、可塑剤であるマクロゴール40010重量
部と共にエタノール1000重M部に溶解させ、展延乾
燥後厚さ約122μmの単層フィルムより成る口腔粘膜
貼付型口臭防止剤を形成した。
<Example 1) Continuously soluble film (adhesive layer): 2.5 parts by weight of °C-menthol, 2.0 parts by weight of mustard oil, and 1.0 parts by weight of fennel shown in Example 1 of Table 1 as active ingredients. 10 parts of hydroxybrobyl cellulose (1-IP C-H),
Hydroxypropylcellulose (HPC-L) 30 parts by weight, polyvinylpyrrolidone (PVP) 44.5ff
The lffi part was dissolved in 1,000 parts by weight of ethanol together with 10 parts by weight of macrogol 40010 as a plasticizer, and after being spread and dried, an oral mucosal adhesive type anti-halitosis agent consisting of a single-layer film with a thickness of about 122 μm was formed.

(実施例2乃至8) 有効成分及びフィルム形成成分を第1表の実施例2乃至
8に示す成分比率′にしたがって変えたものについて、
実施例1と同法により714のI11層フィルムより成
る口腔粘膜貼付型口臭防止剤を形成した。それらの剤厚
は夫々第1表下欄に示した通りである。但し、実施例6
の溶媒は水1000重量部に、実施例7の溶媒は塩化メ
チレン1000重M部に変えである。なお実施例8.1
6中クロロとあるのはクロロフィリン誘導体を示す。
(Examples 2 to 8) Regarding those in which the active ingredients and film-forming ingredients were changed according to the component ratios shown in Examples 2 to 8 in Table 1,
An oral mucosal adhesive type anti-halitosis agent consisting of 714 I11 layer film was formed by the same method as in Example 1. Their thicknesses are shown in the bottom column of Table 1. However, Example 6
The solvent in Example 7 was changed to 1000 parts by weight of water, and the solvent in Example 7 was changed to 1000 parts by weight of methylene chloride. Note that Example 8.1
The chloro in 6 indicates a chlorophyllin derivative.

以上の実施例1乃至8に示した連発溶解性フィルムの口
臭防止剤を口腔内粘膜に貼付して実用性を評価したとこ
ろ、この群の口臭防止剤は口腔粘膜に異和感なく全面付
着し、最後まで剥離せずに口臭を消す作用を発揮し、約
30〜40分経過後完全に溶解した。
When the rapid dissolving film anti-halitosis agents shown in Examples 1 to 8 above were applied to the oral mucosa to evaluate their practicality, this group of anti-halitosis agents adhered to the entire oral mucosa without any discomfort. It exhibited the effect of eliminating bad breath without peeling until the end, and completely dissolved after about 30 to 40 minutes.

(実施例9) 遅発溶解性フィルム(接着層);有効成分として第2表
実施例9に示す(−メントール2.0重量部、ハツカ油
2.0重量部、ウィキミウ0.5重世部を、HPC−H
40重量部、HPC−L20重吊置部PVP35.5重
量部と共にエタノール1000重量部に溶解させ、展延
乾燥後厚さ25.4μmの単層フィルムより成る口腔粘
膜貼付型口臭防止剤を形成した。
(Example 9) Slow-dissolving film (adhesive layer): The active ingredients are shown in Example 9 in Table 2 (-2.0 parts by weight of menthol, 2.0 parts by weight of mustard oil, 0.5 parts by weight of Wikimiu) , HPC-H
It was dissolved in 1000 parts by weight of ethanol together with 40 parts by weight and 35.5 parts by weight of HPC-L20 heavy hanging part PVP to form an oral mucosal adhesive type anti-halitosis agent consisting of a single layer film with a thickness of 25.4 μm after being spread and dried. .

(実施例10乃至16) 有効成分及びフィルム形成成分を第2表の実施例10〜
16に示す成分比率にしたがって変えたものについて実
施例9と同法により7種の単層フィルムより成る口腔粘
膜貼付型口臭防止剤を形成した。
(Examples 10 to 16) The active ingredients and film-forming ingredients were prepared according to Examples 10 to 16 in Table 2.
Using the same method as in Example 9, the oral mucosal adhesive type anti-halitosis agent consisting of seven types of single-layer films was formed using the same method as in Example 9, except for the compositions whose component ratios were changed according to the ratios shown in Example 16.

それらの剤厚は夫々第2表下欄に示した通りである。Their thicknesses are shown in the lower column of Table 2.

以上の実施例9乃至16に示した遅発溶解性フィルム製
口臭防止剤を口腔内粘膜に貼付して実用性を評価したと
ころ、この群の口臭防止剤も口腔粘膜に異和感なく全面
付着し、最後まで剥離せずに口臭を消す作用を発揮し、
約40分〜60分経過後完全に溶解した。
When the slow-dissolving film anti-halitosis agents shown in Examples 9 to 16 were applied to the oral mucosa to evaluate their practicality, this group of anti-halitosis agents also adhered to the entire oral mucosa surface without any discomfort. It exerts the effect of eliminating bad breath without exfoliating until the end,
It was completely dissolved after about 40 to 60 minutes.

(実施例17〜24) 実施例1によって形成した厚さ約122μmの連発溶解
性フィルム(接着層)に、実施例9の成分比率にしたが
って混合溶解したものを展延し、乾燥後厚さ約25μm
の遅発溶解性フイム層を形成した。以上により連発溶解
性フィルムと遅発溶解性フィルムより成る厚さ約147
μm複層の口腔粘膜貼付型口臭防止剤を形成した(第3
表)。
(Examples 17 to 24) A mixture and solution mixed and dissolved according to the component ratio of Example 9 was spread on the continuously dissolvable film (adhesive layer) having a thickness of about 122 μm formed in Example 1, and after drying, a thickness of about 122 μm was spread. 25μm
A slow-dissolving film layer was formed. As a result of the above, the thickness of the continuous dissolving film and the slow dissolving film is approximately 147 cm.
A μm multi-layered oral mucosal adhesive type anti-halitosis agent was formed (3rd
table).

以下類に第1表の実施例2の連発溶解性フィルムと第2
表の実施例10の遅発溶解性フィルムより成る厚さ約1
77μmの複層フィルムから実施例8と実施例16まで
を、第3表上段に示す如く組合せた複層フィルムより成
る口腔粘膜貼付型口臭防止剤を形成した。
The following are the continuous dissolving film of Example 2 in Table 1 and the second
Approximately 1 thick of the slow dissolving film of Example 10 in the table
A 77 μm multilayer film of Example 8 and Example 16 was combined as shown in the upper row of Table 3 to form an oral mucosal adhesive type anti-halitosis agent.

以上の実施例17乃至24の成分の組合せと剤厚は第3
表上段右欄に示しである。これらの複層の口臭防止剤を
口腔粘膜に付着して実用性を評価したところ、口臭を消
す効果を発揮する時間について著しい延伸が見られ、そ
の時間は略剤厚に比例することが確かめられた。しかし
、実施例20のものは剤厚が396μmと基準にした3
30μmを越えたため口腔内違和感を訴える者が見られ
た。
The combination of ingredients and thickness of Examples 17 to 24 above are the same as those of the third embodiment.
It is shown in the upper right column of the table. When we evaluated the practicality of these multi-layer anti-halitosis agents by attaching them to the oral mucosa, we found that the time it took to exert the effect of eliminating bad breath was significantly prolonged, and it was confirmed that this time was proportional to the thickness of the agent. Ta. However, the material of Example 20 had a thickness of 396 μm based on the standard.
Some people complained of discomfort in the oral cavity because the diameter exceeded 30 μm.

(実施例25〜32) 実施例1の連発溶解性フィルムを、実施例9の遅発溶解
性フィルムの両面に展延し、夫々のフィルム厚を合計し
た厚さ約269μmの3FIの口腔粘膜貼付型口臭防止
剤を形成した(実施例25)。
(Examples 25 to 32) The rapid dissolving film of Example 1 was spread on both sides of the slow dissolving film of Example 9, and the total thickness of each film was approximately 269 μm, and 3FI was applied to the oral mucosa. A mold anti-halitosis agent was formed (Example 25).

また第3表下段に示す成分の組合せにより3層の口臭防
止剤を形成した。この群の口臭防止剤は前2群のものに
比較して有効時間が著しく長くなり1時間を越えるもの
も現れた〈実施例27.28)が、同時にそれらは違和
感も顕茗になり、実用に適さないものと判断された。
In addition, a three-layer halitosis preventive agent was formed by combining the ingredients shown in the lower row of Table 3. This group of anti-halitosis agents had a significantly longer effective time than those in the previous two groups, with some lasting over an hour (Examples 27 and 28); was judged to be unsuitable.

(実施例33〜37) この群の実施例はフラボノイド以下5秒を消臭効果のあ
る有効成分として含有するしのであり、水溶性フィルム
は実施例1〜8と同様連発溶解性フィルムを用いている
。しかし遅発溶解性フィルムとの組合せも当然可能であ
る。
(Examples 33 to 37) Examples of this group contain 5 seconds of flavonoid as an active ingredient with a deodorizing effect, and the water-soluble film is a continuous dissolving film similar to Examples 1 to 8. There is. However, a combination with slow-dissolving films is of course also possible.

実施例33は有効成分として第4表に示す通りフラボノ
イド1.0重量部をHPC−840重量部、HPC−L
20重吊置部PVP39重量部と共にエタノール100
0重量部に溶解させ、展延乾燥後厚さ約20μmの単層
フィルムより成る口腔粘膜貼付型口臭防止剤を形成した
例である。
Example 33 contains 1.0 parts by weight of flavonoids as active ingredients as shown in Table 4, HPC-840 parts by weight, and HPC-L.
20 parts by weight of PVP and 100 parts by weight of ethanol
This is an example in which an oral mucosal adhesive type anti-halitosis agent was formed by dissolving 0 parts by weight, spreading and drying, and then forming a single-layer film with a thickness of about 20 μm.

実施例34は有効成分として塩化はチルピリジニウム、
同35は塩化クロルヘキシジン、同36は塩化デカリニ
ウム、同37はグルコン酸クロルヘキシジンを夫々含有
するほか製法は上記と同じである。
Example 34 has chlorpyridinium chloride as the active ingredient;
No. 35 contains chlorhexidine chloride, No. 36 contains dequalinium chloride, and No. 37 contains chlorhexidine gluconate, and the manufacturing method is the same as above.

(実施例38〜42) 矯味、矯臭効果を有するλ−メントール以下の有効成分
と、消臭効果を右するフラボノイド以下の有効成分を併
用した例を第5表に示す。水溶性フィルムは実施例33
〜31と同様連発溶解性フィルムを用いているが、これ
も遅発溶解性フィルムと組合せ可能である。
(Examples 38 to 42) Table 5 shows examples in which an active ingredient below λ-menthol, which has a taste-correcting and odor-correcting effect, and an active ingredient below flavonoid, which has a deodorizing effect, are used together. Water-soluble film is Example 33
Although a rapid dissolving film is used in the same way as in 31, this can also be combined with a slow dissolving film.

実施例38はフラボノイドとぶ−メントール、ハツカ油
を有効成分とした例、同39以下も第5表に示す通りの
各有効成分を含有させて本発明に係る口臭防止剤を形成
した例であり、前記と同様の製法により製造することが
できる。
Example 38 is an example in which flavonoid menthol and peppermint oil were used as active ingredients, and Example 39 and below are examples in which the anti-halitosis agent according to the present invention was formed by containing each active ingredient as shown in Table 5. It can be manufactured by the same manufacturing method as above.

実施例1〜8と実施例9〜16及び実施例33〜31の
相互の組合せについても実施例38〜42と同様に実施
し、殆んど全てを検討したが概して良好な結果が得られ
た。
The mutual combinations of Examples 1 to 8, Examples 9 to 16, and Examples 33 to 31 were carried out in the same manner as Examples 38 to 42, and almost all of them were examined, and generally good results were obtained. .

【図面の簡単な説明】[Brief explanation of the drawing]

図面は本発明に係るロ腔粘膜付型ロ臭防止剤に関するも
ので第1図乃至第5図はいずれも断面構造を示ず拡大断
面図、第6図は本発明の口臭防止効果を示すグラフであ
る。 特 許 出 願 人 救急薬品工業株式会社第3表 第5表 潅悄募仕しとにム 第 図 第2図 第3図
The drawings relate to the breath odor preventive agent with mucosa attached to the oral cavity according to the present invention, and FIGS. 1 to 5 are enlarged cross-sectional views without showing the cross-sectional structure, and FIG. 6 is a graph showing the halitosis preventing effect of the present invention. It is. Patent application Person: Kyuu Yakuhin Kogyo Co., Ltd. Table 3 Table 5 Recruitment services Figure 2 Figure 3

Claims (12)

【特許請求の範囲】[Claims] (1)口臭防止効果を有する有効成分を含有し、口腔粘
膜に付着する水溶性フィルムより成る口腔粘膜貼付型口
臭防止剤。
(1) An oral mucosa patch-type anti-halitosis agent containing an active ingredient having an anti-halitosis effect and consisting of a water-soluble film that adheres to the oral mucosa.
(2)有効成分としてl−メントール、dl−カンフル
、ハッカ油、ウイキョウ油、アセンヤク、カンゾウ、ク
ロロフィリン誘導体、ケイヒ、コショウ、シュクシャ、
ショウキョウ、チョウジ、トウガラシ、dl−メントー
ル、ヒャクソウ、モッコウ、ヤクチ、リュウノウ、ニク
ズク、チョウジ油、ケイヒ油、サフラン、ローズ油、抹
茶から選ばれた1種又は2種以上を含有する請求項第1
項記載の口腔粘膜貼付型口臭防止剤。
(2) Active ingredients include l-menthol, dl-camphor, peppermint oil, fennel oil, acaenia, licorice, chlorophyllin derivatives, cinnamon bark, pepper, shukusha,
Claim 1 containing one or more selected from ginger, clove, chili pepper, dl-menthol, hyakusou, mokko, yakuchi, rhyuno, nikuzuku, clove oil, cinnamon bark oil, saffron, rose oil, and matcha.
The oral mucosal patch type anti-halitosis agent described in 2.
(3)各有効成分の含有比率は、重量比で0.1〜5%
である請求項第2項記載の口腔粘膜貼付型口臭防止剤。
(3) The content ratio of each active ingredient is 0.1 to 5% by weight
The oral mucosa patch type halitosis preventive agent according to claim 2.
(4)有効成分としてフラボノイド、塩化セチルピリジ
ニウム、塩化クロルヘキシジン、塩化デカリニウム、グ
ルコン酸クロルヘキシジンから選ばれた1種又は2種以
上を含有する請求項第1項又は第2項記載の口腔粘膜貼
付型口臭防止剤。
(4) Oral mucosa adhesive type halitosis according to claim 1 or 2, which contains one or more selected from flavonoids, cetylpyridinium chloride, chlorhexidine chloride, dequalinium chloride, and chlorhexidine gluconate as active ingredients. Inhibitor.
(5)各有効成分の含有比率は、重量比で0.01〜5
%である請求項第4項記載の口腔粘膜貼付型口臭防止剤
(5) The content ratio of each active ingredient is 0.01 to 5 by weight.
% of the oral mucosa patch type halitosis preventive agent according to claim 4.
(6)有効成分の他に、防腐剤、人口甘味料その他の食
品添加物を含有した請求項第1項記載の口腔粘膜貼付型
口臭防止剤。
(6) The oral mucosa-type anti-halitosis agent according to claim 1, which contains a preservative, an artificial sweetener, and other food additives in addition to the active ingredient.
(7)水溶性フィルムは、ポリビニルピロリドン、ゼラ
チン、ポリビニルアルコール、ポリアクリル酸ナトリウ
ム、カルボキシメチルセルロース、デンプン、キサンタ
ンガム、カラヤガム、アルギン酸ナトリウム、メチルセ
ルロース、カルボキシビニルポリマー、カンテン、ヒド
ロキシプロピルセルロースから選ばれた1種又は2種以
上を主成分とする請求項第1項記載の口腔粘膜貼付型口
臭防止剤。
(7) The water-soluble film is one type selected from polyvinylpyrrolidone, gelatin, polyvinyl alcohol, sodium polyacrylate, carboxymethylcellulose, starch, xanthan gum, karaya gum, sodium alginate, methylcellulose, carboxyvinyl polymer, agar, and hydroxypropylcellulose. or the oral mucosa patch type halitosis preventive agent according to claim 1, which contains two or more types as main ingredients.
(8)水溶性フィルムが、単層フィルムである請求項第
1項記載の口腔粘膜貼付型口臭防止剤。
(8) The oral mucosa-type anti-halitosis agent according to claim 1, wherein the water-soluble film is a single-layer film.
(9)水溶性フィルムが、複層フィルムである請求項第
1項記載の口腔粘膜貼付型口臭防止剤。
(9) The oral mucosa-type anti-halitosis agent according to claim 1, wherein the water-soluble film is a multilayer film.
(10)水溶性フィルムが、3層以上の積層フィルムで
ある請求項第1項記載の口腔粘膜貼付型口臭防止剤。
(10) The oral mucosa-type anti-halitosis agent according to claim 1, wherein the water-soluble film is a laminated film having three or more layers.
(11)水溶性フィルムの少なくとも一層は他の層より
も持続性を有する遅発溶解性フィルムより成る請求項第
8項、第9項又は第10項記載の口腔粘膜貼付型口臭防
止剤。
(11) The oral mucosal adhesive type anti-halitosis agent according to claim 8, 9, or 10, wherein at least one layer of the water-soluble film is a slow-dissolving film that lasts longer than the other layers.
(12)剤厚即ち水溶性フィルムの厚さが15〜330
μmである請求項第1項記載の口腔粘膜貼付型口臭防止
剤。
(12) The agent thickness, that is, the thickness of the water-soluble film is 15 to 330
The oral mucosal adhesive type anti-halitosis agent according to claim 1, which has a particle size of .mu.m.
JP63209797A 1988-08-24 1988-08-24 Oral cavity mucosa-attaching type halitosis-preventing agent Granted JPH0259513A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63209797A JPH0259513A (en) 1988-08-24 1988-08-24 Oral cavity mucosa-attaching type halitosis-preventing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63209797A JPH0259513A (en) 1988-08-24 1988-08-24 Oral cavity mucosa-attaching type halitosis-preventing agent

Publications (2)

Publication Number Publication Date
JPH0259513A true JPH0259513A (en) 1990-02-28
JPH0541602B2 JPH0541602B2 (en) 1993-06-24

Family

ID=16578754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63209797A Granted JPH0259513A (en) 1988-08-24 1988-08-24 Oral cavity mucosa-attaching type halitosis-preventing agent

Country Status (1)

Country Link
JP (1) JPH0259513A (en)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04134027A (en) * 1990-09-25 1992-05-07 Nisshin:Kk Cleanser composition for denture
US5700478A (en) * 1993-08-19 1997-12-23 Cygnus, Inc. Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
JP2000212094A (en) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd Pharmaceutical preparation for oral cavity
WO2000018365A3 (en) * 1998-09-25 2000-11-16 Warner Lambert Co Fast dissolving orally consumable films
JP2002193731A (en) * 2000-12-27 2002-07-10 Kanebo Ltd Cosmetic
JP2002255772A (en) * 2001-03-01 2002-09-11 Nippon Zettoc Co Ltd Base for composition for oral cavity and composition for oral cavity
WO2003015749A1 (en) * 2001-08-20 2003-02-27 Colgate-Palmolive Company Breath freshening film
KR20030054221A (en) * 2001-12-24 2003-07-02 애경산업(주) Composite film composition for oral cavity and preparing method thereof
EP1337148A2 (en) * 2000-11-30 2003-08-27 Wm. Wrigley Jr. Company Improved pullulan free edible film compositions and methods of making the same
WO2004037237A1 (en) * 2002-10-24 2004-05-06 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
WO2004041230A1 (en) * 2002-11-07 2004-05-21 Taisho Pharmaceutical Co.,Ltd. Base for oral composition and oral composition
WO2005120455A1 (en) * 2004-06-12 2005-12-22 Passion For Life Healthcare Limited Soluble strip for oral or topical administration
JP2007525451A (en) * 2003-04-14 2007-09-06 エフ エム シー コーポレーション Uniform and thermoreversible alginate film delivery system
JP2008509922A (en) * 2004-08-11 2008-04-03 キャドバリー・アダムズ・ユーエスエイ・エルエルシー Sensory initiator composition and delivery system thereof
JP2010270133A (en) * 1996-12-16 2010-12-02 Lts Lohmann Therapie-Systeme Ag Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
JP2013508453A (en) * 2009-10-26 2013-03-07 コルゲート・パーモリブ・カンパニー Oral composition for treating bad breath
JP2013533207A (en) * 2010-01-29 2013-08-22 コルゲート・パーモリブ・カンパニー Oral care formulation for malodor control
JP2015182959A (en) * 2014-03-20 2015-10-22 フタムラ化学株式会社 Water soluble film for inhibiting odor
JP5905989B1 (en) * 2015-10-20 2016-04-20 森 敏明 Bad breath prevention sheet
JP2017178906A (en) * 2016-03-31 2017-10-05 小林製薬株式会社 Oral composition
US10350238B2 (en) 2004-08-02 2019-07-16 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Method of treating xerostomia
US11446255B2 (en) 2019-03-20 2022-09-20 Ricoh Company, Ltd. Sheet, sheet laminate, pharmaceutical drug, sheet producing method, sheet producing apparatus, sheet laminate producing method, and sheet laminate producing apparatus
US12083209B2 (en) 2020-02-18 2024-09-10 Sunstar Americas, Inc. Oral care composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63280014A (en) * 1987-05-12 1988-11-17 Sekisui Chem Co Ltd Plaster composition for bad breath prevention

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63280014A (en) * 1987-05-12 1988-11-17 Sekisui Chem Co Ltd Plaster composition for bad breath prevention

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04134027A (en) * 1990-09-25 1992-05-07 Nisshin:Kk Cleanser composition for denture
US5700478A (en) * 1993-08-19 1997-12-23 Cygnus, Inc. Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
JP2010270133A (en) * 1996-12-16 2010-12-02 Lts Lohmann Therapie-Systeme Ag Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance
US7491406B2 (en) 1998-09-25 2009-02-17 Mcneil-Ppc, Inc. Fast dissolving orally consumable films
WO2000018365A3 (en) * 1998-09-25 2000-11-16 Warner Lambert Co Fast dissolving orally consumable films
JP2002525306A (en) * 1998-09-25 2002-08-13 ワーナー−ランバート・カンパニー Rapidly dissolving oral consumable film
JP2000212094A (en) * 1998-11-18 2000-08-02 Takeda Chem Ind Ltd Pharmaceutical preparation for oral cavity
EP1337148A2 (en) * 2000-11-30 2003-08-27 Wm. Wrigley Jr. Company Improved pullulan free edible film compositions and methods of making the same
EP1337148A4 (en) * 2000-11-30 2005-03-16 Wrigley W M Jun Co Improved pullulan free edible film compositions and methods of making the same
JP2002193731A (en) * 2000-12-27 2002-07-10 Kanebo Ltd Cosmetic
JP2002255772A (en) * 2001-03-01 2002-09-11 Nippon Zettoc Co Ltd Base for composition for oral cavity and composition for oral cavity
WO2003015749A1 (en) * 2001-08-20 2003-02-27 Colgate-Palmolive Company Breath freshening film
KR20030054221A (en) * 2001-12-24 2003-07-02 애경산업(주) Composite film composition for oral cavity and preparing method thereof
WO2004037237A1 (en) * 2002-10-24 2004-05-06 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US7671086B2 (en) 2002-10-24 2010-03-02 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
US7585890B2 (en) 2002-10-24 2009-09-08 Immunpharm A/S Pharmaceutical compositions comprising flavonoids and menthol
WO2004041229A1 (en) * 2002-11-07 2004-05-21 Nippon Zettoc Co.,Ltd. Base for oral composition and oral composition
JPWO2004041229A1 (en) * 2002-11-07 2006-03-02 日本ゼトック株式会社 Oral composition base and oral composition
WO2004041230A1 (en) * 2002-11-07 2004-05-21 Taisho Pharmaceutical Co.,Ltd. Base for oral composition and oral composition
CN100352418C (en) * 2002-11-07 2007-12-05 大正制药株式会社 Base for oral composition and the oral composition
US7393519B2 (en) 2002-11-07 2008-07-01 Taisho Pharmaceutical Co., Ltd. Base for oral composition and the oral composition
JP2007525451A (en) * 2003-04-14 2007-09-06 エフ エム シー コーポレーション Uniform and thermoreversible alginate film delivery system
WO2005120455A1 (en) * 2004-06-12 2005-12-22 Passion For Life Healthcare Limited Soluble strip for oral or topical administration
US10350238B2 (en) 2004-08-02 2019-07-16 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Method of treating xerostomia
JP2008509922A (en) * 2004-08-11 2008-04-03 キャドバリー・アダムズ・ユーエスエイ・エルエルシー Sensory initiator composition and delivery system thereof
JP2013508453A (en) * 2009-10-26 2013-03-07 コルゲート・パーモリブ・カンパニー Oral composition for treating bad breath
JP2013533207A (en) * 2010-01-29 2013-08-22 コルゲート・パーモリブ・カンパニー Oral care formulation for malodor control
JP2015131835A (en) * 2010-01-29 2015-07-23 コルゲート・パーモリブ・カンパニーColgate−Palmolive Company Oral care formulation for malodor control
US9504857B2 (en) 2010-01-29 2016-11-29 Colgate-Palmolive Company Oral care formulations for malodor control
JP2015182959A (en) * 2014-03-20 2015-10-22 フタムラ化学株式会社 Water soluble film for inhibiting odor
JP5905989B1 (en) * 2015-10-20 2016-04-20 森 敏明 Bad breath prevention sheet
JP2017078036A (en) * 2015-10-20 2017-04-27 森 敏明 Bad breath prevention sheet
JP2017178906A (en) * 2016-03-31 2017-10-05 小林製薬株式会社 Oral composition
US11446255B2 (en) 2019-03-20 2022-09-20 Ricoh Company, Ltd. Sheet, sheet laminate, pharmaceutical drug, sheet producing method, sheet producing apparatus, sheet laminate producing method, and sheet laminate producing apparatus
US12083209B2 (en) 2020-02-18 2024-09-10 Sunstar Americas, Inc. Oral care composition

Also Published As

Publication number Publication date
JPH0541602B2 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
JPH0259513A (en) Oral cavity mucosa-attaching type halitosis-preventing agent
US5700478A (en) Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US9161909B2 (en) Adhesive compositions for the treatment of xerostomia
US4876092A (en) Sheet-shaped adhesive preparation applicable to oral cavity
US6210699B1 (en) Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
AU2003240824B9 (en) Transmucosal delivery of cannabinoids
WO2003105800A2 (en) Film-shaped mucoadhesive administration form for administering cannabis active ingredients
UA67802C2 (en) CONTROLLED-RELEASE FORMULATIONS FOR ORAL ADMINISTRATION CONTAINING cGMP PDE-5 INHIBITOR (VARIANTS), METHOD FOR ITS PREPARATION AND METHOD FOR TREATING ERECTILE DYSFUNCTION
KR20090020561A (en) Film-coated solid dosage forms
US20140161744A1 (en) Composition with activated carbon in oral treatment
JPH059412B2 (en)
ZA200508801B (en) Transmucosal form of administration with reduced mucosal irritation
JP2001288074A (en) Film-formed troche
US20120015021A1 (en) Anti-appetite adhesive compositions
US6045825A (en) Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit
US20090053309A1 (en) Adhesive compositions for the treatment of xerostomia
PL209144B1 (en) Solid orally-dispersible pharmaceutical formulation
JPS6136491B2 (en)
US5716635A (en) Plantago major transdermal patch for use in treating a tobacco or nicotine habit
JP2000063268A (en) Oral mucosa adhesion-type controlled release troche and periodontal disease therapeutic agent
US6063401A (en) Plantago major and hypericum perforatum compound for use in treating a tobacco or nicotine habit
DE10338544B4 (en) Buccal formulations of galanthamine and their applications
KR20050021003A (en) Film-shaped mucoadhesive administration form for administering cannabis active ingredients
JP2006182669A (en) Patch for oral cavity
JP2005289939A (en) Oral cavity patch

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees